Complement-Based Drug Development Summit leaderboard
  • Wednesday, August 26, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

17th World ADC San Diego Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 269

Author

Pharma Journalist 9023 posts 0 comments

Vertex to Acquire ViaCyte, With the Goal of Accelerating its Potentially Curative VX-880 Programs in…

Jul 11, 2022
Vertex Pharmaceuticals Incorporated announced that the company has entered into a definitive agreement under which Vertex will acquire ViaCyte, a privately held biotechnology company…
Read More...

WuXi XDC and AbTis Sign Memorandum of Understanding for Development and Manufacturing of Antibody…

Jul 11, 2022
WuXi XDC, a global leading CRDMO (Contract Research, Development and Manufacturing Organization) dedicated to end-to-end bioconjugates services, and AbTis, a Korean biotechnology…
Read More...

ADC Therapeutics Announces Exclusive License Agreement with Sobi to Develop and Commercialize…

Jul 11, 2022
ADC Therapeutics SA announced it has entered into an exclusive license agreement with Swedish Orphan Biovitrum AB (Sobi) for the development and commercialization of ZYNLONTA for all…
Read More...

Pfizer and BioNTech Announce FDA Approval of their COVID-19 Vaccine COMIRNATY For Adolescents 12…

Jul 11, 2022
Pfizer Inc. and BioNTech SE announced the U.S. Food and Drug Administration (FDA) approved the companies’ supplemental Biologics License Application (sBLA) for their COVID-19 vaccine,…
Read More...

FDA Approves KRYSTEXXA (pegloticase) Injection Co-Administered With Methotrexate, Expanding the…

Jul 11, 2022
Horizon Therapeutics plc announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) expanding the labeling to include…
Read More...

FDA Releases Draft Guidance on CMC For Individualized ASO Therapies

Jul 11, 2022
SAE Media Group reports: the Oligonucleotide Therapeutics Conference will touch on the Draft Guidance on CMC for Individualized ASO Therapies SAE Media Group proudly presents the…
Read More...

Network with Johnson & Johnson, Springboard, BSI, AstraZeneca and many more at the Wearable…

Jul 8, 2022
SAE Media Group reports: The full agenda and speaker line-up are now available to download for the 3rd Annual Wearable Injectors and Connected Devices Conference, returning in October…
Read More...

Exelixis and Ryvu Therapeutics Establish Exclusive License Agreement to Develop Novel STING…

Jul 8, 2022
Exelixis, Inc. and Ryvu Therapeutics S.A. announced that the companies have entered into an exclusive license agreement focused on the development of novel targeted therapies utilizing…
Read More...

BeiGene Announces Strategic Research Collaboration with InnoRNA to Jointly Discover Novel mRNA…

Jul 8, 2022
BeiGene announced it entered into a worldwide strategic collaboration with InnoRNA, a biotechnology company with expertise in LNP-based delivery technology and mRNA drug discovery, to…
Read More...

Brii Biosciences Announces Commercial Launch of its Amubarvimab/Romlusevimab Combination Therapy for…

Jul 7, 2022
Brii Biosciences Limited, a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public health burdens, and TSB…
Read More...
Prev Next
Microbiome Movement USA Summit 2026
Cell Therapy for Autoimmune Disease Summit
Complement-Based Drug Development Summit
World CNS Summit South Korea
Novel CNS Biomarkers Summit Europe
8th CNS Drug Delivery Summit
Biomarker Operations & Biospecimen Management
2nd Obesity & Weight Loss Drug Development Summit Europe
RNA-Based Therapeutics & Vaccines Summit South Korea
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
Neuropsychiatric Drug Development Summit
10th IPF Summit
Model-Informed Drug Development Summit 2026
IMPACCT Real-World Evidence Summit
Raw Materials for Cell & Gene Therapy Summit
Cell & Gene Therapy Summit South Korea
10th Dermatology Drug Development Summit
9th Lab Asset & Facility Management Summit
TRP Supply Chain & Manufacturing Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • REGENXBIO Delays RGX-121 Filing After Spine MRI Findings
  • Lundbeck Wins EU Orphan Designation for Cushing’s Syndrome Drug
  • Takeda Wins Japan Approval for New Narcolepsy Type 1 Drug
  • GSK Wins Japan Approval for Hepatitis B Functional Cure
  • Gossamer Bio Secures Up to $250 Million for Seralutinib

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

2nd T-Cell Engager for Autoimmune Disease Summit to Deliver…

2nd T-Cell Engager for Autoimmune Disease Summit Returns in…

New Era for Autoimmune T-Cell Engagers Takes Centre Stage…

From Innovation to Acquisition: CrossBridge Bio’s ADC…

COPD Foundations Joins the COPD Drug Development Summit

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.